BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 38526928)

  • 21. An Overview of the Methodology Used to Develop Clinical Practice Guidelines for the Management of Acute and Intraoperative Spinal Cord Injury.
    Tetreault LA; Skelly AC; Alvi MA; Kwon BK; Evaniew N; Fehlings MG
    Global Spine J; 2024 Mar; 14(3_suppl):25S-37S. PubMed ID: 38526928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clinical Practice Guideline on the Timing of Surgical Decompression and Hemodynamic Management of Acute Spinal Cord Injury and the Prevention, Diagnosis, and Management of Intraoperative Spinal Cord Injury: Introduction, Rationale, and Scope.
    Tetreault LA; Kwon BK; Evaniew N; Alvi MA; Skelly AC; Fehlings MG
    Global Spine J; 2024 Mar; 14(3_suppl):10S-24S. PubMed ID: 38632715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Update of a Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Role and Timing of Decompressive Surgery.
    Fehlings MG; Tetreault LA; Hachem L; Evaniew N; Ganau M; McKenna SL; Neal CJ; Nagoshi N; Rahimi-Movaghar V; Aarabi B; Hofstetter CP; Wengel VT; Nakashima H; Martin AR; Kirshblum S; Rodrigues Pinto R; Marco RAW; Wilson JR; Kahn DE; Newcombe VFJ; Zipser CM; Douglas S; Kurpad SN; Lu Y; Saigal R; Samadani U; Arnold PM; Hawryluk GWJ; Skelly AC; Kwon BK
    Global Spine J; 2024 Mar; 14(3_suppl):174S-186S. PubMed ID: 38526922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on Hemodynamic Management.
    Kwon BK; Tetreault LA; Martin AR; Arnold PM; Marco RAW; Newcombe VFJ; Zipser CM; McKenna SL; Korupolu R; Neal CJ; Saigal R; Glass NE; Douglas S; Ganau M; Rahimi-Movaghar V; Harrop JS; Aarabi B; Wilson JR; Evaniew N; Skelly AC; Fehlings MG
    Global Spine J; 2024 Mar; 14(3_suppl):187S-211S. PubMed ID: 38526923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2023 AO Spine-Praxis Guidelines in Acute Spinal Cord Injury: What Have We Learned? What Are the Critical Knowledge Gaps and Barriers to Implementation?
    Fehlings MG; Moghaddamjou A; Evaniew N; Tetreault LA; Alvi MA; Skelly AC; Kwon BK
    Global Spine J; 2024 Mar; 14(3_suppl):223S-230S. PubMed ID: 38526926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critically Low Confidence in the Results Produced by Spine Surgery Systematic Reviews: An AMSTAR-2 Evaluation From 4 Spine Journals.
    Dettori JR; Skelly AC; Brodt ED
    Global Spine J; 2020 Aug; 10(5):667-673. PubMed ID: 32677574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant Systematic Reviews: Which to Believe?
    Dettori JR; Norvell DC
    Global Spine J; 2020 Apr; 10(2):237-239. PubMed ID: 32206523
    [No Abstract]   [Full Text] [Related]  

  • 29. GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks.
    Foroutan F; Guyatt G; Zuk V; Vandvik PO; Alba AC; Mustafa R; Vernooij R; Arevalo-Rodriguez I; Munn Z; Roshanov P; Riley R; Schandelmaier S; Kuijpers T; Siemieniuk R; Canelo-Aybar C; Schunemann H; Iorio A
    J Clin Epidemiol; 2020 May; 121():62-70. PubMed ID: 31982539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RoB 2: a revised tool for assessing risk of bias in randomised trials.
    Sterne JAC; Savović J; Page MJ; Elbers RG; Blencowe NS; Boutron I; Cates CJ; Cheng HY; Corbett MS; Eldridge SM; Emberson JR; Hernán MA; Hopewell S; Hróbjartsson A; Junqueira DR; Jüni P; Kirkham JJ; Lasserson T; Li T; McAleenan A; Reeves BC; Shepperd S; Shrier I; Stewart LA; Tilling K; White IR; Whiting PF; Higgins JPT
    BMJ; 2019 Aug; 366():l4898. PubMed ID: 31462531
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence to Decision framework provides a structured "roadmap" for making GRADE guidelines recommendations.
    Li SA; Alexander PE; Reljic T; Cuker A; Nieuwlaat R; Wiercioch W; Guyatt G; Schünemann HJ; Djulbegovic B
    J Clin Epidemiol; 2018 Dec; 104():103-112. PubMed ID: 30253221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for the Management of Degenerative Cervical Myelopathy and Acute Spinal Cord Injury: Development Process and Methodology.
    Tetreault LA; Skelly AC; Dettori JR; Wilson JR; Martin AR; Fehlings MG
    Global Spine J; 2017 Sep; 7(3 Suppl):8S-20S. PubMed ID: 29164037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
    Shea BJ; Reeves BC; Wells G; Thuku M; Hamel C; Moran J; Moher D; Tugwell P; Welch V; Kristjansson E; Henry DA
    BMJ; 2017 Sep; 358():j4008. PubMed ID: 28935701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp).
    Vernooij RW; Alonso-Coello P; Brouwers M; Martínez García L;
    PLoS Med; 2017 Jan; 14(1):e1002207. PubMed ID: 28072838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
    Sterne JA; Hernán MA; Reeves BC; Savović J; Berkman ND; Viswanathan M; Henry D; Altman DG; Ansari MT; Boutron I; Carpenter JR; Chan AW; Churchill R; Deeks JJ; Hróbjartsson A; Kirkham J; Jüni P; Loke YK; Pigott TD; Ramsay CR; Regidor D; Rothstein HR; Sandhu L; Santaguida PL; Schünemann HJ; Shea B; Shrier I; Tugwell P; Turner L; Valentine JC; Waddington H; Waters E; Wells GA; Whiting PF; Higgins JP
    BMJ; 2016 Oct; 355():i4919. PubMed ID: 27733354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.
    Alonso-Coello P; Oxman AD; Moberg J; Brignardello-Petersen R; Akl EA; Davoli M; Treweek S; Mustafa RA; Vandvik PO; Meerpohl J; Guyatt GH; Schünemann HJ;
    BMJ; 2016 Jun; 353():i2089. PubMed ID: 27365494
    [No Abstract]   [Full Text] [Related]  

  • 37. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
    Alonso-Coello P; Schünemann HJ; Moberg J; Brignardello-Petersen R; Akl EA; Davoli M; Treweek S; Mustafa RA; Rada G; Rosenbaum S; Morelli A; Guyatt GH; Oxman AD;
    BMJ; 2016 Jun; 353():i2016. PubMed ID: 27353417
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.
    Tierney JF; Vale C; Riley R; Smith CT; Stewart L; Clarke M; Rovers M
    PLoS Med; 2015 Jul; 12(7):e1001855. PubMed ID: 26196287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.
    Iorio A; Spencer FA; Falavigna M; Alba C; Lang E; Burnand B; McGinn T; Hayden J; Williams K; Shea B; Wolff R; Kujpers T; Perel P; Vandvik PO; Glasziou P; Schunemann H; Guyatt G
    BMJ; 2015 Mar; 350():h870. PubMed ID: 25775931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.